The FDA approved Boston Scientific's Infinion 16 Percutaneous Lead for its Precision Plus Spinal Cord Stimulator system, according to a news release.
This is the first 16-contact percutaneous lead for spinal cord stimulation. Traditionally, leads, which deliver electrical pulses from an implantable pulse generator to the spinal cord, have had a maximum of eight contact points. The extra leads will provide better coverage of the painful area of the spinal cord.
The Infinion 16 Lead will be introduced at the North American Neuromodulation Society meeting that begins today.
Related Articles on Pain Management:
Medical Marijuana Used With Opiates Could Help Patients Reduce Pain
Prevalence of Knee Pain, Symptomatic Knee Osteoarthritis Increasing
BioLineRx Drug Gets Positive Results in Clinical Trial for Neuropathic Pain
This is the first 16-contact percutaneous lead for spinal cord stimulation. Traditionally, leads, which deliver electrical pulses from an implantable pulse generator to the spinal cord, have had a maximum of eight contact points. The extra leads will provide better coverage of the painful area of the spinal cord.
The Infinion 16 Lead will be introduced at the North American Neuromodulation Society meeting that begins today.
Related Articles on Pain Management:
Medical Marijuana Used With Opiates Could Help Patients Reduce Pain
Prevalence of Knee Pain, Symptomatic Knee Osteoarthritis Increasing
BioLineRx Drug Gets Positive Results in Clinical Trial for Neuropathic Pain